Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
100,740,741
-
Number of holders
-
190
-
Total 13F shares, excl. options
-
71,176,129
-
Shares change
-
-784,087
-
Total reported value, excl. options
-
$2,470,272,742
-
Value change
-
-$31,512,282
-
Put/Call ratio
-
422%
-
Number of buys
-
82
-
Number of sells
-
-104
-
Price
-
$34.71
Significant Holders of FIBROGEN INC - Common Stock, $0.01 par value (FGEN) as of Q1 2021
243 filings reported holding FGEN - FIBROGEN INC - Common Stock, $0.01 par value as of Q1 2021.
FIBROGEN INC - Common Stock, $0.01 par value (FGEN) has 190 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 71,176,129 shares
of 100,740,741 outstanding shares and own 70.65% of the company stock.
Largest 10 shareholders include PRIMECAP MANAGEMENT CO/CA/ (11,771,758 shares), VANGUARD GROUP INC (7,792,851 shares), BlackRock Inc. (7,626,057 shares), FMR LLC (5,719,181 shares), HILLHOUSE CAPITAL ADVISORS, LTD. (3,955,787 shares), JANUS HENDERSON GROUP PLC (3,284,267 shares), STATE STREET CORP (3,021,009 shares), Bank of New York Mellon Corp (2,331,898 shares), JPMORGAN CHASE & CO (2,179,430 shares), and PRICE T ROWE ASSOCIATES INC /MD/ (1,898,067 shares).
This table shows the top 190 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.